市場調査レポート
商品コード
1123092
タンパク質工学の世界市場:2022年~2028年Global Protein Engineering Market Research and Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
タンパク質工学の世界市場:2022年~2028年 |
出版日: 2022年07月20日
発行: Orion Market Research
ページ情報: 英文 150 Pages
納期: 2~3営業日
|
世界のタンパク質工学の市場規模は、予測期間(2022年~2028年)中に約12.5%の大幅なCAGRで拡大すると予測されています。タンパク質工学は、作物収量の増加やバイオ燃料の生産を促進する機能を向上させた酵素の生成につながる可能性があるため、農薬産業において非常に大きな機会をもたらします。また、将来のニーズに応えるために必要な作物収量の増加を達成するためのツールとしても重要な役割を果たすとみられています。
当レポートでは、世界のタンパク質工学市場について調査し、市場の概要とともに、タンパク質タイプ別、製品別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。世界のタンパク質工学市場、タンパク質タイプ別
世界のタンパク質工学市場、製品別
世界のタンパク質工学市場、エンドユーザー別
16.
Global Protein Engineering Market Size, Share & Trends Analysis Report by Technology (Rational Protein Design and Irrational Protein Design), by Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Colony Stimulating Factor, Coagulation Factor, Vaccines, and Others), By Product (Instruments, Services and Software, and Reagents), and by End-User (Academic Research Institutes, Pharmaceutical, and Biotechnology Companies, and Contract Research Organizations), and Forecast 2022-2028
The global protein engineering market is anticipated to grow at a significant CAGR of around 12.5% during the forecast period (2022-2028). Protein engineering holds an immense opportunity in the agrochemical industry as engineering in proteins may lead to the generation of enzymes with an improved function that may increase the crop yield or facilitate biofuel production. It is also likely to play an important role as a tool to attain increased crop yield needed to meet future needs. Some methods are used for protein engineering such as site-directed mutagenesis, random mutagenesis, random mutagenesis, homology modeling, cell surface display technology, and DNA shuffling technology. Protein engineering has various applications as biocatalysts from medical, environmental to nanobiotechnology. The rising focus of pharmaceutical and biotechnology companies on research & development of protein-based drugs due to advantages over non-protein drugs, such as higher cost-effectiveness and improved patient outcomes are the major factors driving the market growth.
Moreover, the surging strategic collaborations among prominent players of market is another key factor for the market development. For instance, in Jan 2021 Zymvol Biomodelling, S.L collaborated with Aminoverse B.V, a biotech company specializing in enzyme discovery and design, to develop custom-made alcohol dehydrogenases, an enzyme most commonly used in the flavors and fragrances and the fine chemicals industry. Apart from these, increasing public and private investments in synthetic biology, and continuous advancements in protein engineering technologies are expected to offer new growth opportunities to the market during the forecast period.
Impact of COVID-19 Pandemic on Global Protein Engineering Market
The field of protein engineering is widely driven by research. For instance, amid COVID-19 pandemic, in March 2020, a team of scientists from North America found out that Protein mapping finds 69 potential treatments for COVID-19.
Segmental Outlook
The global protein engineering market is segmented based on protein type, product, and end-user. Based on technology, the market is sub-segmented into rational protein design and irrational protein design. Based on protein type, the market is sub-segmented into monoclonal antibodies, insulin, erythropoietin, interferon, colony-stimulating factor, coagulation factor, vaccines, and others. Among these, monoclonal antibodies segment is projected to register the fastest revenue growth rate in the global market over the projected period owing to the increasing R&D activities for advanced monoclonal antibodies. Based on product, the market is sub-segmented into instruments, service and software, and reagents. Based on end-user, the market is sub-segmented into academic research institutes, pharmaceutical and biotechnology companies, and CROs.
Global Protein Engineering Market Share by Protein Type, 2021 (%)
Global Parkinson Disease Drug Market Growth, by Region
Monoclonal Antibodies segment is expected to be the largest contributor in the global protein engineering market
Monoclonal antibodies are anticipated to hold the largest share over the forecast period owing to their high adoption for numerous therapies such as cancer and autoimmune diseases. The increasing prevalence of cancer and other autoimmune diseases has significantly increased the use of monoclonal bodies for the treatment of diseases. They also have tremendous applications in the fields of therapeutics, diagnostics, and targeted drug delivery systems for infectious diseases caused by viruses, bacteria, protozoa, and many more. Hence, recombinant deoxyribonucleic acid technology, through genetic engineering, has successfully led to the possibility of the reconstruction of monoclonal antibodies, which is the driving factor for the growth of the market.
Regional Outlook
The global protein engineering market is further segmented based on geography including North America (the US and Canada), Europe (Italy, Spain, Germany, France, Rest of Europe), Asia Pacific (India, China, Japan, South Korea, Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa).
Global Protein Engineering Market, by Region 2022-2028
Global Protein Engineering Market, by Region
The Asia-Pacific region is estimated to hold a major share in the Global Protein Engineering Market
Asia-Pacific is expected to witness the fastest CAGR during the forecast period, due to the growing presence of contract research organizations, rising healthcare IT spending, and unprecedented evolution of the healthcare infrastructure and standards across the region. Growing demand for personalized medicine and strong R&D investments in proteomics-based drug discovery projects are also supplementing the growth of the protein engineering market. In addition, proteomics R&D initiatives coupled with significant funding for protein-based drug research and advancements in genomics in several Asia Pacific countries are likely to offer new growth opportunities to the market during the forecast period.
Major Players Outlooks
The major companies serving the global protein engineering market include AB SCIEX, LLC, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, Waters Corp., GenScript Biotech Corp, Thermo Fisher Scientific Inc, General Electric Co, Eli Lilly and Co, and Novartis International AG and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches to stay competitive in the market. For instance, in January 2019, Amunix Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery and development of novel immune-oncology therapeutics entered into a licensing agreement with Merck for rights to develop therapeutics against an undisclosed target using Amunix's proprietary protease-triggered immune activator (ProTIA) technology platform. The powerful new platform technology enabled the rapid generation of tumor activatable cytokines, signaling peptides/proteins or immune cell engagers.
The report covers
Market value data analysis of 2022 and forecast to 2028
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global protein engineering market
Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market
Global Protein Engineering Market by Protein Type
Global Protein Engineering Market by Product
Global Protein Engineering Market by End-User
4.1.12 Academic Research Institutes
4.1.13 Pharmaceutical and Biotechnology Companies
4.1.14 Contract Research Organizations (CROs)
5.4.1 Latin America
5.4.2 Middle East and Africa